IGF1LR3 (Insulin-like Growth Factor 1 Receptor Variant 3) – 1 mg

IGF1LR3 refers to a genetically engineered variant of the human insulin-like growth factor 1 (IGF-1) receptor, specifically designed for academic and biochemical research applications. This peptide variant is of interest in the study of receptor signaling pathways, cellular responses, and potential mechanisms of growth factor action. Below are detailed considerations regarding its research context and applications.

Research Context

IGF-1 receptors (IGF-1R) play a crucial role in mediating growth, differentiation, and metabolism in eukaryotic cells. The IGF-1R pathway is extensively studied in both healthy and pathological conditions, including cancer progression, aging, and metabolic disorders. IGF1LR3 variants are sometimes investigated in research settings to explore variations in binding affinity, downstream signaling dynamics, or functional outcomes compared to native IGF-1R forms. These studies contribute to a deeper understanding of receptor biology and potential therapeutic targets.

Research Overview

IGF1LR3 is often utilized in research to analyze receptor-ligand interactions, signal transduction, and cellular responses. Its inclusion in in vitro assays may provide insights into how specific mutations or modifications affect receptor function, which can be critical for developing targeted treatments in disease modeling or biochemical studies. This peptide is not intended for any therapeutic, diagnostic, or cosmetic use and is strictly for academic or biochemical research applications only.

Key Research Focus Areas

• Binding Affinity Studies: Investigation of how IGF1LR3 interacts with IGF-1 ligands and other growth factors, influencing receptor activation and downstream signaling pathways.
• Receptor Mutant Analysis: Examination of functional differences between IGF1LR3 variants and native IGF-1R in cellular or animal models, including effects on proliferation, apoptosis, and metabolic processes.
• Signal Transduction Pathways: Assessment of how IGF1LR3-mediated activation influences intracellular signaling cascades, such as PI3K/Akt, MAPK/ERK, and JAK/STAT pathways.
• Biochemical and Pharmacological Characterization: Evaluation of IGF1LR3’s stability, half-life, and potential toxicological profiles in experimental settings.
• Genetic and Epigenetic Studies: Exploration of IGF1LR3’s role in gene regulation, chromatin dynamics, or epigenetic modifications within model organisms or cell lines.

This peptide variant is provided as a research chemical for use solely in academic or biochemical laboratories. Researchers must adhere to all applicable ethical guidelines, institutional policies, and regulatory standards governing its use.

Important Compliance Statement

For research use only. Not for human or animal consumption. Always consult with a qualified scientific advisor or regulatory authority before initiating any research involving IGF1LR3 or similar peptides. Responsibility for proper storage, handling, and disposal of research chemicals rests with the user.